ACR-368

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of premium spirits bottles and market screens illustrating the Pernod Ricard SA and Brown-Forman Corporation merger talks that could reshape the global spirits industry.

Pernod Ricard and Brown-Forman confirm merger talks that could reshape the global spirits industry

Judge blocks Pentagon from blacklisting Anthropic: ‘Classic First Amendment retaliation’

Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform

Representative image of a laboratory skin research setting illustrating the kind of translational science behind Rubedo Life Sciences’ RLS-1496 Phase 1 dermatology results in psoriasis, atopic dermatitis, and skin aging.

Aging biotech just got a real skin test and Rubedo Life Sciences may have passed the first one

Acrivon Therapeutics strengthens precision oncology pipeline with ACR-368 Phase 2b success and new AP3-enabled candidates

Find out how Acrivon Therapeutics is advancing precision oncology with positive ACR-368 Phase 2b data, EU trial expansion, and new AP3-enabled pipeline candidates.

bySoujanya Ravi

January 8, 2026

How to detect proteins Biuret Test and other scientific methods explained

FDA grants breakthrough device designation to Acrivon’s OncoSignature assay for endometrial cancer

Acrivon Therapeutics has secured a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its…

byPallavi Madhiraju

February 5, 2025

The Latest

Pernod Ricard and Brown-Forman confirm merger talks that could reshape the global spirits industry

Judge blocks Pentagon from blacklisting Anthropic: ‘Classic First Amendment retaliation’

Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform

Aging biotech just got a real skin test and Rubedo Life Sciences may have passed the first one

Acrivon Therapeutics strengthens precision oncology pipeline with ACR-368 Phase 2b success and new AP3-enabled candidates

FDA grants breakthrough device designation to Acrivon’s OncoSignature assay for endometrial cancer

Pernod Ricard and Brown-Forman confirm merger talks that could reshape the global spirits industry

Judge blocks Pentagon from blacklisting Anthropic: ‘Classic First Amendment retaliation’

Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform

Aging biotech just got a real skin test and Rubedo Life Sciences may have passed the first one

Can deeper university alliances help Propanc Biopharma, Inc. stabilize its clinical transition?

Canada and Prince Edward Island sign impact assessment agreement to cut project review duplication

Biocytogen just stacked two cancer bets in three days. Is its platform strategy starting to compound?